Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (541-550 of 999) with videos related to

Pageof 100
Sort By:
Circulation|January 10, 2016
N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) StudyChiadi E Ndumele, Kunihiro Matsushita, Yingying Sang, et al.
Archives of Internal Medicine|November 30, 2005
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) studyChristie M Ballantyne, Ron C Hoogeveen, Heejung Bang, et al.
American Journal of Preventive Cardiology|January 30, 2026
Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKMMichael Miller, Deepak L Bhatt, Eliot A Brinton, et al.
Journal of Proteomics|December 5, 2022
A proteomic approach for investigating the pleiotropic effects of statins in the atherosclerosis risk in communities (ARIC) studyBruno Bohn, Pamela L Lutsey, Weihong Tang, et al.
Journal of the American Heart Association|January 23, 2023
Magnetic Resonance Imaging-Derived Microvascular Perfusion Modeling to Assess Peripheral Artery DiseaseOlga A Gimnich, Tatiana Belousova, Christina M Short, et al.
Diabetes, Obesity & Metabolism|June 26, 2007
Genetic variation and decreased risk for obesity in the Atherosclerosis Risk in Communities StudyM L Hart Sailors, A R Folsom, C M Ballantyne, et al.
Atherosclerosis|July 17, 1999
Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis StudyK Sing, C M Ballantyne, L Ferlic, et al.
European Heart Journal|April 2, 2014
High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities studyAndrea L C Schneider, Andreea M Rawlings, A Richey Sharrett, et al.
Kansas Journal of Medicine|December 21, 2020
E-cigarette Use and Risk Behaviors among Lesbian, Gay, Bisexual, and Transgender Adults: The Behavioral Risk Factor Surveillance System (BRFSS) SurveyMahmoud Al Rifai, Mohammadhassan Mirbolouk, Xiaoming Jia, et al.
Research and Practice in Thrombosis and Haemostasis|November 21, 2017
Galectin-3 and Venous Thromboembolism Incidence: the Atherosclerosis Risk in Communities (ARIC) StudyOluwaseun E Fashanu, Susan R Heckbert, David Aguilar, et al.
Pageof 100

Showing results (541-550 of 999) with videos related to

Sort By:
Pageof 100
Circulation|January 10, 2016
N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) StudyChiadi E Ndumele, Kunihiro Matsushita, Yingying Sang, et al.
Archives of Internal Medicine|November 30, 2005
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) studyChristie M Ballantyne, Ron C Hoogeveen, Heejung Bang, et al.
American Journal of Preventive Cardiology|January 30, 2026
Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKMMichael Miller, Deepak L Bhatt, Eliot A Brinton, et al.
Journal of Proteomics|December 5, 2022
A proteomic approach for investigating the pleiotropic effects of statins in the atherosclerosis risk in communities (ARIC) studyBruno Bohn, Pamela L Lutsey, Weihong Tang, et al.
Journal of the American Heart Association|January 23, 2023
Magnetic Resonance Imaging-Derived Microvascular Perfusion Modeling to Assess Peripheral Artery DiseaseOlga A Gimnich, Tatiana Belousova, Christina M Short, et al.
Diabetes, Obesity & Metabolism|June 26, 2007
Genetic variation and decreased risk for obesity in the Atherosclerosis Risk in Communities StudyM L Hart Sailors, A R Folsom, C M Ballantyne, et al.
Atherosclerosis|July 17, 1999
Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis StudyK Sing, C M Ballantyne, L Ferlic, et al.
European Heart Journal|April 2, 2014
High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities studyAndrea L C Schneider, Andreea M Rawlings, A Richey Sharrett, et al.
Kansas Journal of Medicine|December 21, 2020
E-cigarette Use and Risk Behaviors among Lesbian, Gay, Bisexual, and Transgender Adults: The Behavioral Risk Factor Surveillance System (BRFSS) SurveyMahmoud Al Rifai, Mohammadhassan Mirbolouk, Xiaoming Jia, et al.
Research and Practice in Thrombosis and Haemostasis|November 21, 2017
Galectin-3 and Venous Thromboembolism Incidence: the Atherosclerosis Risk in Communities (ARIC) StudyOluwaseun E Fashanu, Susan R Heckbert, David Aguilar, et al.
Pageof 100